Literature DB >> 1924702

The use of transgenic mice in unraveling the multistep process of tumorigenesis.

M Breuer1.   

Abstract

The development of cancer has long been perceived to be a complex and multistep process in which a normal cell progresses to a fully malignant tumor cell in a step-by-step fashion. At the molecular level it is believed that these steps correspond to the acquisition of activated oncogenes or alternatively the inactivation of tumor suppressor genes. With the ability to stably transfer foreign genetic information into the germ line of animals a new powerful tool to study oncogenes became available.

Entities:  

Mesh:

Year:  1991        PMID: 1924702     DOI: 10.1007/bf01226614

Source DB:  PubMed          Journal:  Radiat Environ Biophys        ISSN: 0301-634X            Impact factor:   1.925


  9 in total

Review 1.  Provirus tagging as an instrument to identify oncogenes and to establish synergism between oncogenes.

Authors:  A Berns
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

2.  Very high frequency of lymphoma induction by a chemical carcinogen in pim-1 transgenic mice.

Authors:  M Breuer; R Slebos; S Verbeek; M van Lohuizen; E Wientjens; A Berns
Journal:  Nature       Date:  1989-07-06       Impact factor: 49.962

3.  Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo.

Authors:  E Sinn; W Muller; P Pattengale; I Tepler; R Wallace; P Leder
Journal:  Cell       Date:  1987-05-22       Impact factor: 41.582

4.  Deregulated c-fos expression interferes with normal bone development in transgenic mice.

Authors:  U Rüther; C Garber; D Komitowski; R Müller; E F Wagner
Journal:  Nature       Date:  1987 Jan 29-Feb 4       Impact factor: 49.962

5.  Predisposition to lymphomagenesis in pim-1 transgenic mice: cooperation with c-myc and N-myc in murine leukemia virus-induced tumors.

Authors:  M van Lohuizen; S Verbeek; P Krimpenfort; J Domen; C Saris; T Radaszkiewicz; A Berns
Journal:  Cell       Date:  1989-02-24       Impact factor: 41.582

6.  Acceleration of B-lymphoid tumorigenesis in E mu-myc transgenic mice by v-H-ras and v-raf but not v-abl.

Authors:  W Y Langdon; A W Harris; S Cory
Journal:  Oncogene Res       Date:  1989

Review 7.  Transgenic mice as a means to study synergism between oncogenes.

Authors:  A Berns; M Breuer; S Verbeek; M van Lohuizen
Journal:  Int J Cancer Suppl       Date:  1989

8.  An E mu-v-abl transgene elicits plasmacytomas in concert with an activated myc gene.

Authors:  H Rosenbaum; A W Harris; M L Bath; J McNeall; E Webb; J M Adams; S Cory
Journal:  EMBO J       Date:  1990-03       Impact factor: 11.598

9.  N-myc is frequently activated by proviral insertion in MuLV-induced T cell lymphomas.

Authors:  M van Lohuizen; M Breuer; A Berns
Journal:  EMBO J       Date:  1989-01       Impact factor: 11.598

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.